What is a Monarch Drug? A Deep Dive into Corporate Legacy and Pharmacological Concepts
•
4 min read
In 2010, Pfizer announced its acquisition of King Pharmaceuticals for $3.6 billion, a deal which included King's subsidiary, Monarch Pharmaceuticals [1.4.9, 1.5.3]. When asking 'What is a monarch drug?', the answer usually points to a legacy product from this company, though the term also has an entirely different, classical meaning in pharmacology.
